ATE95704T1 - Anwendung heterozyklischer derivate zur herstellung von arzneimitteln. - Google Patents

Anwendung heterozyklischer derivate zur herstellung von arzneimitteln.

Info

Publication number
ATE95704T1
ATE95704T1 AT87311081T AT87311081T ATE95704T1 AT E95704 T1 ATE95704 T1 AT E95704T1 AT 87311081 T AT87311081 T AT 87311081T AT 87311081 T AT87311081 T AT 87311081T AT E95704 T1 ATE95704 T1 AT E95704T1
Authority
AT
Austria
Prior art keywords
pharmaceuticals
manufacture
application
heterocyclic derivatives
antagonist
Prior art date
Application number
AT87311081T
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE95704T1 publication Critical patent/ATE95704T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87311081T 1986-12-17 1987-12-16 Anwendung heterozyklischer derivate zur herstellung von arzneimitteln. ATE95704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630080A GB8630080D0 (en) 1986-12-17 1986-12-17 Medicaments
EP87311081A EP0272876B1 (de) 1986-12-17 1987-12-16 Anwendung heterozyklischer Derivate zur Herstellung von Arzneimitteln

Publications (1)

Publication Number Publication Date
ATE95704T1 true ATE95704T1 (de) 1993-10-15

Family

ID=10609121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87311081T ATE95704T1 (de) 1986-12-17 1987-12-16 Anwendung heterozyklischer derivate zur herstellung von arzneimitteln.

Country Status (10)

Country Link
EP (1) EP0272876B1 (de)
JP (1) JPS63246337A (de)
AT (1) ATE95704T1 (de)
AU (1) AU618943B2 (de)
CA (1) CA1314223C (de)
DE (1) DE3787796T2 (de)
DK (1) DK662487A (de)
ES (1) ES2059399T3 (de)
GB (1) GB8630080D0 (de)
ZA (1) ZA879459B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
WO1993012817A1 (en) * 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
SI0723436T1 (en) * 1994-07-08 2002-02-28 Astrazeneca Ab Multiple unit tableted dosage form i
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
WO1997047285A1 (en) * 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
CA2524268A1 (en) * 2003-05-06 2004-11-18 Altana Pharma Ag Proton pump inhibitors for the treatment of lower abdominal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
CA1303047C (en) * 1986-03-17 1992-06-09 Alexander W. Oxford Imidazolyl indole derivatives

Also Published As

Publication number Publication date
JPS63246337A (ja) 1988-10-13
GB8630080D0 (en) 1987-01-28
DK662487A (da) 1988-06-18
EP0272876A3 (en) 1988-07-27
AU618943B2 (en) 1992-01-16
DK662487D0 (da) 1987-12-16
EP0272876A2 (de) 1988-06-29
AU8261587A (en) 1988-06-23
DE3787796T2 (de) 1994-03-03
ES2059399T3 (es) 1994-11-16
ZA879459B (en) 1988-11-30
CA1314223C (en) 1993-03-09
DE3787796D1 (de) 1993-11-18
EP0272876B1 (de) 1993-10-13

Similar Documents

Publication Publication Date Title
SE8406585L (sv) Bensoesyraderivat
ATE109481T1 (de) Diazinderivate als angiotensin ii rezeptor antagonisten.
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
DK0540526T3 (da) Quinuclidinderivater
BG60249B2 (en) Thiazole compound for treatment of ulcers
ATE152623T1 (de) Verwendung von heterozyklischen derivaten zur herstellung von arzneimitteln
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
ATE95704T1 (de) Anwendung heterozyklischer derivate zur herstellung von arzneimitteln.
ATE119524T1 (de) Substituierte n-(imidazolyl)alkyl-alanin- derivate.
ATE112166T1 (de) Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE81016T1 (de) Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.
DK0401093T3 (da) Hidtil ukendte pyrrolidonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse
ATE42100T1 (de) 2-(n-pyrrolidino)-3-isobutoxy-n-phenyl substituierte n-benzylpropylamine, ihre herstellung und ihre pharmazeutische anwendung.
PT78155A (de) N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung
ATE73997T1 (de) Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.
NO158675C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater.
ATE8260T1 (de) 2-(n-(2-fluor-6-bromphenyl)-n-(thiemyl-2-methyl - amino)-2-imidazolin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
SE8105297L (sv) Imidazolderivat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee